Elevated tph2 mRNA expression in a rat model of chronic anxiety

Depression and Anxiety

Volumn 29, Issue 4, 2012, Pages 307-319

  Donner, Nina C ^a   Johnson, Philip L ^b   Fitz, Stephanie D ^b   Kellen, Karen E ^a   Shekhar, Anantha ^b   Lowry, Christopher A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anxiety anxiety disorders; biological markers; mood disorders; panic attacks agoraphobia; stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; MESSENGER RNA; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE 2; UROCORTIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; BASOLATERAL AMYGDALA; CONFERENCE PAPER; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; GENE; GENETIC VARIABILITY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; TPH2 GENE;

AMYGDALA; ANIMALS; ANXIETY DISORDERS; DISEASE MODELS, ANIMAL; MALE; RAPHE NUCLEI; RATS; RATS, WISTAR; RNA, MESSENGER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE; UP-REGULATION;

EID: 84860617631     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21925     Document Type: Conference Paper

References (98)

1. Fink M, Akimova E, Spindelegger C, et al. Social anxiety disorder: epidemiology, biology and treatment. Psychiatr Danub 2009; 21 (4): 533-542.
2. Stein D,. Panic disorder: the psychobiology of external treat and introceptive distress. CNS Spectr 2008; 13 (1): 26-30. (Pubitemid 351224279)
3. Greenberg P, Sisitsky T, Kessler R, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999; 60 (7): 427-435. (Pubitemid 29369796)
4. Karsnitz D, Ward S,. Spectrum of anxiety disorders: diagnosis and pharmacologic treatment. J Midwifery Womens Health 2011; 56 (3): 266-281.
5. Hoffman DL, Dukes EM, Wittchen H-U,. Human and economic burden of generalized anxiety disorder. Depress Anxiety 2008; 25 (1): 72-90. (Pubitemid 351213928)
6. Shekhar A, Sajdyk TS, Keim SR, et al. Role of the basolateral amygdala in panic disorder. Ann NY Acad Sci 1999; 877: 747-750. (Pubitemid 29351905)
7. Rauch SL, Shin LM, Wright CI,. Neuroimaging studies of amygdala function in anxiety disorders. Ann NY Acad Sci 2003; 985 (1): 389-410. (Pubitemid 36521129)
8. Naughton M, Mulrooney JB, Leonard BE,. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol 2000; 15 (6): 397-415.
9. Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF,. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 1996; 54 (1): 129-141. (Pubitemid 26146666)
10. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301 (5631): 386-389. (Pubitemid 36877077)
11. Kendler KS, Kuhn JW, Prescott CA,. Childhood sexual abuse, stressful life events and risk for major depression in women. Psychol Med 2004; 34 (8): 1475-1482. (Pubitemid 39599945)
12. Hammen C,. Association between recent stressful life events and prevalence of depression, anxiety and PTSD differs according to exposure to childhood adversity. Evid Based Ment Health 2011; 14 (1): 9.
13. Sandi C, Cordero MI, Ugolini A, et al. Chronic stress-induced alterations in amygdala responsiveness and behavior-modulation by trait anxiety and corticotropin-releasing factor systems. Eur J Neurosci 2008; 28 (9): 1836-1848.
14. Kozicz T, Bordewin LA, Czeh B, et al. Chronic psychosocial stress affects corticotropin-releasing factor in the paraventricular nucleus and central extended amygdala as well as urocortin 1 in the non-preganglionic Edinger-Westphal nucleus of the tree shrew. Psychoneuroendocrinology 2008; 33 (6): 741-754.
15. Gallagher JP, Orozco-Cabal LF, Liu J, Shinnick-Gallagher P,. Synaptic physiology of central CRH system. Eur J Pharmacol 2008; 583 (2-3): 215-225.
16. Vaughan J, Donaldson C, Bittencourt J, et al. 1995. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin- releasing factor. Nature 378 (6554): 287-292.
17. Gehlert DR, Shekhar A, Morin SM, et al. Stress and central urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. Eur J Pharmacol 2005; 509 (2-3): 145-153. (Pubitemid 40282587)
18. Sanders SK, Shekhar A,. Anxiolytic effects of chlordiazepoxide blocked by injection of GABAA and benzodiazepine receptor antagonists in the region of the anterior basolateral amygdala of rats. Biol Psychiatry 1995; 37 (7): 473-476.
19. Sanders SK, Shekhar A,. Regulation of anxiety by GABAA receptors in the rat amygdala. Pharmacol Biochem Behav 1995; 52 (4): 701-706. (Pubitemid 3005245)
20. Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A,. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 1999; 100 (1-2): 207-215. (Pubitemid 29130255)
21. Shekhar A, Truitt W, Rainnie D, Sajdyk T,. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 2005; 8 (4): 209-219. (Pubitemid 43163254)
22. Bhatnagar S, Vining C, Denski K,. Regulation of chronic stress-induced changes in hypothalamic-pituitary-adrenal activity by the basolateral amygdala. Ann NY Acad Sci 2004; 1032: 315-319. (Pubitemid 40298505)
23. Gilabert-Juan J, Castillo-Gomez E, Perez-Rando M, et al. Chronic stress induces changes in the structure of interneurons and in the expression of molecules related to neuronal structural plasticity and inhibitory neurotransmission in the amygdala of adult mice. Exp Neurol 2011; 232 (1): 33-40.
24. Qin M, Xia Z, Huang T, Smith CB,. Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice. Neuroscience 2011; 194: 282-290.
25. Rainnie DG, Bergeron R, Sajdyk TJ, et al. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 2004; 24 (14): 3471-3479. (Pubitemid 38481103)
26. Sajdyk TJ, Keim SR, Thielen SR, et al. Measurement of panic-like responses following intravenous infusion of sodium lactate in panic-prone rats. Curr Protoc Neurosci 2003; 9 (17): 1-19.
27. Peskind ER, Jensen CF, Pascualy M, et al. Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder. Biol Psychiatry 1998; 44 (10): 1007-1016. (Pubitemid 28545229)
28. Rifkin A, Siris SG,. Panic disorder: response to sodium lactate and treatment with antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 1985; 9 (1): 33-38. (Pubitemid 15149141)
29. Hettema JM, Neale MC, Kendler KS,. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001; 158 (10): 1568-1578. (Pubitemid 32923644)
30. Maron E, Shlik J,. Serotonin function in panic disorder: important, but why ? Neuropsychopharmacology 2006; 31 (1): 1-11. (Pubitemid 43250937)
31. Zhang X, Beaulieu J, Sotnikova T, et al. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004; 305 (5681): 217. (Pubitemid 38886729)
32. Kim YK, Lee HJ, Yang JC, et al. A tryptophan hydroxylase 2 gene polymorphism is associated with panic disorder. Behav Genet 2009; 39 (2): 170-175.
33. Maron E, Toru I, Must A, et al. Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder. Neurosci Lett 2007; 411 (3): 180-184. (Pubitemid 44828280)
34. Maron E, Toru I, Tasa G, et al. 2008. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers. Neurosci Lett 446 (2-3): 88-92.
35. Campos SB, Miranda DM, Souza BR, et al. Association study of tryptophan hydroxylase 2 gene polymorphisms in bipolar disorder patients with panic disorder comorbidity. Psychiatr Genet 2011; 21 (2): 106-111.
36. Yoon HK, Yang JC, Lee HJ, Kim YK,. The association between serotonin-related gene polymorphisms and panic disorder. J Anxiety Disord 2008; 22 (8): 1529-1534.
37. Mossner R, Freitag CM, Gutknecht L, et al. The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder. J Psychopharmacol 2006; 20 (4): 547-552. (Pubitemid 43875184)
38. Bakker A, van Balkom AJ, van Dyck R,. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia. Int Clin Psychopharmacol 2000; 15 (Suppl 2): S25-S30.
39. Hamilton SP, Heiman GA, Haghighi F, et al. Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatr Genet 1999; 9 (1): 1-6.
40. Olesen OF, Bennike B, Hansen ES, et al. The short/long polymorphism in the serotonin transporter gene promoter is not associated with panic disorder in a Scandinavian sample. Psychiatr Genet 2005; 15 (3): 159. (Pubitemid 41231935)
41. Deckert J, Catalano M, Heils A, et al. Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr Genet 1997; 7 (1): 45-47. (Pubitemid 27356821)
42. Domschke K, Braun M, Ohrmann P, et al. Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 2006; 9 (3): 349-355. (Pubitemid 43780503)
43. Blaya C, Salum GA, Lima MS, et al. Lack of association between the serotonin transporter promoter polymorphism (5-HTTLPR) and panic disorder: a systematic review and meta-analysis. Behav Brain Funct 2007; 3: 41 - 51.
44. Blaya C, Salum GA, Moorjani P, et al. Panic disorder and serotonergic genes (SLC6A4, HTR1A and HTR2A): association and interaction with childhood trauma and parenting. Neurosci Lett 2010; 485 (1): 11-15.
45. Strug LJ, Suresh R, Fyer AJ, et al. Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Mol Psychiatry 2010; 15 (2): 166-176.
46. Gyawali S, Subaran R, Weissman MM, et al. Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder. Biol Psychiatry 2010; 67 (4): 331-338.
47. Maron E, Tasa G, Toru I, et al. Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers. World J Biol Psychiatry 2004; 5 (3): 149-154. (Pubitemid 44121709)
48. Spiga F, Lightman SL, Shekhar A, Lowry CA,. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons. Neuroscience 2006; 138 (4): 1265-1276. (Pubitemid 43363543)
49. Esler M, Lambert E, Alvarenga M, et al. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor. Stress 2007; 10 (3): 295-304. (Pubitemid 47037202)
50. Johnson P, Lowry C, Truitt W, Shekhar A,. Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic. J Psychopharmacol 2008; 22 (6): 642-652.
51. Garber JC, Barbee RW, Bielitzki JT, et al. Guide for the Care and Use of Laboratory Animals (Institute for Laboratory Animal Research). Washington, DC: The National Academies Press; 2011.
52. Paxinos G, Watson C,. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press; 1998.
53. File SE., 1980. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Meth 2 (3): 219-238. (Pubitemid 10050361)
54. Gardner KL, Hale MW, Oldfield S, et al. Adverse experience during early life and adulthood interact to elevate tph2 mRNA expression in serotonergic neurons within the dorsal raphe nucleus. Neuroscience 2009; 163 (4): 991-1001.
55. Sajdyk TJ, Shekhar A,. Excitatory amino acid receptors in the basolateral amygdala regulate anxiety responses in the social interaction test. Brain Res 1997; 764 (1-2): 262-264. (Pubitemid 27380667)
56. Shekhar A, Katner JS,. Dorsomedial hypothalamic GABA regulates anxiety in the social interaction test. Pharmacol Biochem Behav 1995; 50 (2): 253-258.
57. Donner N, Handa RJ,. Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 2009; 163 (2): 705-718.
58. Gardner KL, Hale MW, Lightman SL, et al. Adverse early life experience and social stress during adulthood interact to increase serotonin transporter mRNA expression. Brain Res 2009; 1305: 47-63.
59. Abrams JK, Johnson PL, Hollis JH, Lowry CA,. Anatomic and functional topography of the dorsal raphe nucleus. Ann NY Acad Sci 2004; 1018: 46-57. (Pubitemid 38951389)
60. Grubbs FE,. Procedures for detecting outlying observations in samples. Technometrics 1969; 11: 1-21.
61. Gardner KL, Thrivikraman KV, Lightman SL, et al. Early life experience alters behavior during social defeat: focus on serotonergic systems. Neuroscience 2005; 136 (1): 181-191. (Pubitemid 41483846)
62. Shanks N, Larocque S, Meaney MJ,. Neonatal endotoxin exposure alters the development of the hypothalamic-pituitary-adrenal axis: early illness and later responsivity to stress. J Neurosci 1995; 15 (1 Pt 1): 376-384.
63. Shanks N, Lightman SL,. The maternal-neonatal neuro-immune interface: are there long-term implications for inflammatory or stress-related disease ? J Clin Invest 2001; 108 (11): 1567-1573. (Pubitemid 33144864)
64. Sidor MM, Amath A, MacQueen G, Foster JA,. A developmental characterization of mesolimbocortical serotonergic gene expression changes following early immune challenge. Neuroscience 2010; 171 (3): 734-746.
65. Cowley DS, Dunner DL,. Response to sodium lactate in panic disorder: relationship to presenting clinical variables. Psychiatry Res 1988; 25 (3): 253-259.
66. Gorman JM, Goetz RR, Dillon D, et al. Sodium D-lactate infusion of panic disorder patients. Neuropsychopharmacology 1990; 3 (3): 181-189.
67. Roche M, Commons KG, Peoples A, Valentino RJ,. Circuitry underlying regulation of the serotonergic system by swim stress. J Neurosci 2003; 23 (3): 970-977. (Pubitemid 36206188)
68. Kelly KJ, Donner NC, Hale MW, Lowry CA,. Swim stress activates serotonergic and nonserotonergic neurons in specific subdivisions of the rat dorsal raphe nucleus in a temperature-dependent manner. Neuroscience 2011; 197: 251-268.
69. Johnson PL, Fitz SD, Hollis JH, et al. Induction of c-Fos in 'panic/defence'-related brain circuits following brief hypercarbic gas exposure. J Psychopharmacol 2010; 25 (1): 26-36.
70. Johnson PL, Hollis JH, Moratalla R, et al. Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rats. J Psychopharmacol 2005; 19 (4): 327-341. (Pubitemid 41003128)
71. Johnson PL, Lightman SL, Lowry CA,. A functional subset of serotonergic neurons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic. Ann NY Acad Sci 2004; 1018: 58-64. (Pubitemid 38951390)
72. Johnson PL, Truitt WA, Fitz SD, et al. Neural pathways underlying lactate-induced panic. Neuropsychopharmacology 2008; 33 (9): 2093-2107. (Pubitemid 351992091)
73. Steinbusch H., Serotonin-immunoreactive neurons and their projections in the CNS. In:, Björklund A, Hökfelt T, editors. Classical Transmitters and Transmitter Receptors in the CNS. Amsterdam: Elsevier Science Publishers B.V; 1984: 68-125.
74. Kerman IA, Shabrang C, Taylor L, et al. Relationship of presympathetic-premotor neurons to the serotonergic transmitter system in the rat brainstem. J Comp Neurol 2006; 499 (6): 882-896. (Pubitemid 44892816)
75. Bandler R, Keay KA, Floyd N, Price J,. Central circuits mediating patterned autonomic activity during active vs. passive emotional coping. Brain Res Bull 2000; 53 (1): 95-104.
76. Keay KA, Bandler R,. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev 2001; 25 (7-8): 669-678. (Pubitemid 34136896)
77. Graeff FG,. Anxiety, panic and the hypothalamic-pituitary-adrenal axis. Revista Brasileira de Psiquiatria 2007; 29: 3-6.
78. Underwood MD, Arango V, Bakalian MJ, et al. Dorsal raphe nucleus serotonergic neurons innervate the rostral ventrolateral medulla in rat. Brain Res 1999; 824 (1): 45-55. (Pubitemid 29222884)
79. Bago M, Dean C,. Sympathoinhibition from ventrolateral periaqueductal gray mediated by 5-HT(1A) receptors in the RVLM. Am J Physiol Regul Integr Comp Physiol 2001; 280 (4): R976-R984.
80. Bago M, Sprtel BM, Dean C,. Modulation of sympathetic nerve activity by microinjection of the 5-HT1A receptor agonist 8-OH-DPATinto the rostroventrolateral medulla. J Auton Nerv Syst 1999; 76 (2-3): 127-134. (Pubitemid 29322034)
81. Ljubic-Thibal V, Morin A, Diksic M, Hamel E,. Origin of the serotonergic innervation to the rat dorsolateral hypothalamus: retrograde transport of cholera toxin and upregulation of tryptophan hydroxylase mRNA expression following selective nerve terminals lesion. Synapse 1999; 32 (3): 177-186. (Pubitemid 29222647)
82. Yoshida K, McCormack S, Espana RA, et al. Afferents to the orexin neurons of the rat brain. J Comp Neurol 2006; 494 (5): 845-861. (Pubitemid 43054230)
83. Johnson PL, Truitt W, Fitz SD, et al. A key role for orexin in panic anxiety. Nat Med 2010; 16 (1): 111-115.
84. Kumar S, Szymusiak R, Bashir T, et al. Effects of serotonin on perifornical-lateral hypothalamic area neurons in rat. Eur J Neurosci 2007; 25 (1): 201-212. (Pubitemid 46096234)
85. Abrams JK, Johnson PL, Hay-Schmidt A, et al. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 2005; 133 (4): 983-997. (Pubitemid 40814606)
86. Waterhouse BD, Mihailoff GA, Baack JC, Woodward DJ,. Topographical distribution of dorsal and median raphe neurons projecting to motor, sensorimotor, and visual cortical areas in the rat. J Comp Neurol 1986; 249 (4):460-476, 478-481.
87. Ranade SP, Mainen ZF,. Transient firing of dorsal raphe neurons encodes diverse and specific sensory, motor, and reward events. J Neurophysiol 2009; 102 (5): 3026-3037.
88. Pfleiderer B, Zinkirciran S, Michael N, et al. Altered auditory processing in patients with panic disorder: a pilot study. World J Biol Psychiatry 2010; 11 (8): 945-955.
89. Hale MW, Lowry CA,. Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits. Psychopharmacology (Berl): 2011; 213 (2-3): 243-264.
90. Maron E, Toru I, Hirvonen J, et al. Gender differences in brain serotonin transporter availability in panic disorder. J Psychopharmacol 2011; 25 (7): 952-959.
91. Klein DF,. Testing the suffocation false alarm theory of panic disorder. Anxiety 1994; 1 (1): 1-7.
92. Klein DF,. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 1993; 50 (4): 306-317. (Pubitemid 23115374)
93. Davies SJ, Lowry CA, Nutt DJ,. Panic and hypertension: brothers in arms through 5-HT ? J Psychopharmacol 2007; 21 (6): 563-566. (Pubitemid 47472728)
94. Walker DL, Davis M,. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 1997; 17 (23): 9375-9383. (Pubitemid 27498464)
95. Walker DL, Toufexis DJ, Davis M,. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 2003; 463 (1-3): 199-216. (Pubitemid 36205081)
96. Hayano F, Nakamura M, Asami T, et al. Smaller amygdala is associated with anxiety in patients with panic disorder. Psychiatry Clin Neurosci 2009; 63 (3): 266-276.
97. Graeff FG,. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 2004; 28 (3): 239-259. (Pubitemid 38844374)
98. Lowry C, Hale M,. Serotonin and the neurobiology of anxious states. In:, Mueller C, Jacobs B, editors. Handbook of Behavioral Neuroscience. Amsterdam: Elsevier; 2010: 379-397.